Charles Divita Jr.
CEO
Teladoc Health
Leadership History
1 leader · Full leadership timeline
Charles Divita Jr. is the CEO of Teladoc Health.
| Name | Role | From | To | Years in role |
|---|---|---|---|---|
| Charles Divita Jr. | CEO | — | Present | — |
Teladoc Health, Inc. (NYSE: TDOC) is the global leader in whole-person virtual care, headquartered in Purchase, New York. Founded in 2002, Teladoc broke down geographic barriers to healthcare by enabling patients to consult with state-licensed, board-certified physicians remotely 24/7/365. Today, Teladoc Health operates across two core reporting segments: Integrated Care (~$1.45B in revenue, encompassing enterprise virtual urgent care, Primary360 primary care, chronic condition management programs, and hospital inpatient telehealth systems) and BetterHelp (~$1.15B in revenue, representing the world's largest direct-to-consumer virtual therapy and mental counseling platform). Serving over 92 million insured US members and partnering with thousands of enterprise employers, labor unions, and health plans (including Aetna, UnitedHealthcare, and Blue Cross Blue Shield), Teladoc facilitates more than 20 million telehealth visits annually. Under the strategic direction of Chief Executive Officer Charles 'Chuck' Divita Jr., Teladoc Health is executing a disciplined operational pivot focused on bottom-line margin expansion, capital efficiency, AI-augmented clinical documentation, and the deeper integration of chronic condition management (diabetes, hypertension, weight health) into primary care workflows. Teladoc Health represents an institutional pillar within its global sector, maintaining expansive operations, robust customer and partner relationships, and mission-critical operating infrastructure. Operating on a significant scale across domestic and international markets, Teladoc Health continues to expand its technological and operational capabilities, integrating automated digital workflows, enterprise-grade data security protocols, and advanced operational systems to maximize service reliability and long-term operating efficiency. The enterprise remains focused on capital discipline, scalable operational economics, and strategic customer expansion across high-value market segments. continuous investment in specialized research, modern distribution networks, and skilled workforce development enables Teladoc Health to anticipate regulatory changes, mitigate emerging market risks, and deliver dependable performance for millions of clients, patients, or consumers worldwide.
Teladoc Health operates a diversified recurring virtual care business model spanning B2B enterprise subscriptions, per-visit fees, and direct-to-consumer digital health subscriptions: (1) Integrated Care PMPM Subscriptions (~56% of revenue / ~$1.45B), charging employers and health plans a predictable Per-Member-Per-Month (PMPM) access fee covering 92M+ members, supplemented by visit co-pays; (2) Chronic Condition Enrollment Fees: Monetizing bundled per-participant monthly fees for Livongo diabetes, hypertension, and weight management programs that supply smart cellular blood glucose meters, test strips, and digital coaching; (3) BetterHelp Direct-to-Consumer Subscriptions (~44% of revenue / ~$1.15B), charging consumers monthly recurring subscriptions ($260–$360/month) for weekly live video therapy sessions and unlimited text messaging with licensed therapists; and (4) Enterprise Hospital Virtual Care Systems: Selling specialized hardware carts, software licenses, and tele-stroke/tele-ICU networks to acute hospital systems. Teladoc generates gross margins near 70% and over $350 million in annual adjusted EBITDA.
CEO
These officers report to the chief executive and are not part of the CEO timeline above.
Teladoc Health navigates key operational headwinds: (1) BetterHelp Customer Acquisition Cost Pressures: Rising digital advertising costs on Meta and Google along with consumer discretionary spending sensitivity impacting direct-to-consumer therapy subscriber retention; (2) Intense Digital Health Competition: Rival virtual care platforms from Amwell, MDLIVE (Evernorth/Cigna), and health plan in-house virtual offerings; (3) Chronic Care Enrollment Velocity: Motivating employees enrolled in employer-sponsored health plans to actively register and engage with Livongo diabetes programs; and (4) Historical Goodwill Impairment: Navigating historical balance sheet non-cash write-downs from the peak-valuation Livongo acquisition.
Teladoc Health is led by Chief Executive Officer Charles Divita Jr., who oversees corporate strategy, global operations, and the execution of the firm's strategic modernization roadmap.
Under Charles Divita Jr.'s direction, Teladoc Health's executive team focuses on digital platform innovation, customer acquisition, operational efficiency, disciplined capital allocation, and proactive risk compliance.
Teladoc Health operates under a rigorous corporate governance model governed by an independent Board of Directors with specialized audit, risk, governance, and compensation oversight committees.
Leadership at Teladoc Health fosters a culture grounded in customer-centric service, technological innovation, ethical integrity, community responsibility, and long-term financial prudence.
Compare executive leadership tenures and strategic transitions
Explore Teladoc Health
Core profile pages, founders and related research hubs for this company.